Skip to content

DocGo DCGO Increase (Decrease) in Accounts Receivable

Increase (Decrease) in Accounts Receivable at other companies

ARD
Ardent Health PartnersARDT
-$32K-100%
CVS Health logo
CVS HealthCVS
Medline, Inc.
 logo
Medline, Inc. MDLN

Other financials

Income statement

See full
Revenue$75.6M-21.3%
Gross profit-$407.9M-25.6%
Operating income-$18.7M-33.7%
Net income-$14.8M-57.0%
EPS (diluted)-$0.15-66.7%

Balance sheet

See full
Cash & equivalents$46.8M-54.6%
Total debt$28.5M-7.6%
Total equity$132.3M-57.2%
Total assets$209.2M-51.4%

Cash flow

See full
Operating cash flow-$4.7M-151%
CapEx$430.3K-58.2%
Free cash flow-$5.1M-162%

Valuation

See full
Market cap$50.98M-67.2%
Enterprise value$32.67M-59.1%
P/S0.2×-0.2×

Profitability

See full
Operating margin-60.6%
Net margin-62.2%
FCF margin14.6%+8.1pp

Returns & leverage

See full
Return on equity-85%
Debt / equity0.2×+0.1×
Current ratio1.8×-0.7×

Where this comes from

Reported directly by DocGo in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: DocGo’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about DocGo's increase (decrease) in accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DocGo's increase (decrease) in accounts receivable?
DocGo (DCGO) reported increase (decrease) in accounts receivable of $2.8M in Q1 2026.
How has DocGo's increase (decrease) in accounts receivable changed year-over-year?
DocGo's increase (decrease) in accounts receivable increased by 108.9% year-over-year, from -$31.44M to $2.8M.
What is the long-term trend for DocGo's increase (decrease) in accounts receivable?
Over 4 years (2021 to 2025), DocGo's increase (decrease) in accounts receivable has grown at a 18.0% compound annual growth rate (CAGR), from $58M to -$112.5M.